Sun Pharma – Milmet Labs merger

Sun Pharma Announces China NMPA Approval For ILUMETRI (Tildrakizumab Injection) For Treatment Of Adults with Moderate-To-Severe Plaque Psoriasis Source link

Sun Pharma and Philogen enter into an Exclusive Distribution, License, and Supply Agreement for Commercializing specialty product, NIDLEGY™ in Europe,...

Sun Pharma to announce fourth quarter results on May 26, 2023 Source link

Sun Pharma launches CEQUA, a novel therapy for Dry Eye Disease in India Source link

Osteoarthritis Candidate MM-II Showed Durable Pain Relief in Global Phase 2b Study Source link

Late-Breaking Phase 3 Data at AAD 2023 Show Oral Investigational Medicine Deuruxolitinib Significantly Improved Scalp Hair Regrowth in Alopecia Areata...